US 9771428
CD47 targeted therapies for the treatment of infectious disease
granted A61KA61K2039/505A61K38/1774
Quick answer
US patent 9771428 (CD47 targeted therapies for the treatment of infectious disease) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K38/1774, A61P, A61P31/12